NeuroMetrix (NURO) Reports Q2 adj.-Loss of $0.92/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NURO Hot Sheet
Join SI Premium – FREE
NeuroMetrix (NASDAQ: NURO) reported Q2 EPS of ($0.92), versus ($0.52) reported last year. Revenue for the quarter came in at $2.65 million, versus $1.22 million reported last year.
For earnings history and earnings-related data on NeuroMetrix (NURO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Progyny (PGNY) Tops Q3 EPS by 21c ; Offers Guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
